Nelson Chan
Twist Bioscience has appointed Nelson Chan to its board of directors. Chan has been an advisor to Twist for the last 18 months for the firm's DNA data storage business. Chan is also chairman of the board at Synaptics and Adesto, as well as executive chairman of HZO. He previously served as CEO of Magellan and has also held various senior management roles at SanDisk Corporation. Chan will replace Paul Conley, managing director of Paladin Capital Group, who has served on Twist's board since 2013.
David Fenstermacher
DNAnexus has hired David Fenstermacher as VP of precision medicine and data services. Fenstermacher will supervise the vendor's data management products for precision health and drug discovery applications. Fenstermacher, a molecular biologist and informatician, previously served as VP of R&D bioinformatics at MedImmune. He also had been chief research information officer at Virginia Commonwealth University and was the founding chair of the Department of Biomedical Informatics at the H. Lee Moffitt Cancer Center.
Sangeeta Bhorade
Veracyte has hired Sangeeta Bhorade as medical director of pulmonology to lead medical affairs for the firm's pulmonology products. Bhorade joins Veracyte from Northwestern University Feinberg School of Medicine, where she served as professor of medicine and medical director of the lung transplant program. Prior to Northwestern, Bhorade served as medical director of the lung transplant program at the University of Chicago Medical Center. She has also served as associate medical director of lung transplant at Loyola University Chicago.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.